Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician.

Objective: To describe practice patterns for care of Canadian patients with moderate to severe plaque psoriasis.

Design: Online survey of a consumer panel.

Setting: Participants were drawn from a population-wide Canadian consumer database.

A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis.

Background: Psoriasis is a chronic inflammatory disease associated with comorbidities and decreased quality of life. This survey is aimed to better understand the impact of disease on Canadian patients, and to examine awareness and use of available treatment options.

Methods: An online survey was conducted using a consumer panel.

A Canadian self-administered online survey to evaluate the impact of moderate-to-severe psoriasis among patients.

Background: Few population studies of individuals living with psoriasis have been performed in Canada.

Objective: The objective of this survey was to understand the severity and impact of psoriasis on the lives of Canadian patients.

Methods: An online survey was conducted using a consumer panel.

[Liver dysfunction in recipients of hematopoietic stem cells. Impact on mortality].

Liver disease is a well-known cause of early morbidity and mortality affecting 80% of patients receiving allogeneic bone-marrow transplantation (BMT). Drug toxicity, veno-occlusive disease (VOD), acute graft-versus-host disease (GVHD), and fungal, bacterial, and viral infections are the most frequent hepatic complications during this period. The aim of this retrospective study was to determine the prevalence and etiology of liver disease and its impact on mortality as well as to assess the predictive value of pre BMT hepatic biochemical tests on the subsequent occurrence of acute and/or chronic GVHD and patient mortality.

[When is the best time to perform upper digestive endoscopy to detect the presence of esophageal varices in patients with cirrhosis?].

Introduction: Variceal hemorrhage occurs in 25 to 35% of cirrhotic patients and is associated with significant morbidity and mortality and elevated hospital costs. Endoscopic exploration of gastroesophageal varices (GEV) in cirrhotic patients increases costs and involves a certain degree of invasiveness and discomfort for patients. The association between the presence of GEV and spleen size, liver function and platelet count is controversial.